2026. Structure-Based Design and Computational Validation of Novel 1,3,4-Thiadiazole-Peptide Conjugates as Selective Cyclin-Dependent Kinase-2 (CDK2) Inhibitors for Lung Cancer Therapy. Pakistan Journal of Medical & Cardiological Review. 5, 2 (Apr. 2026), 1174–1180. DOI:https://doi.org/10.66021/pakmcr903.